Physician profile

Ariel E Holley

Obstetrics · Raleigh, NC

NPI 1679777247

$305.48

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$16.85

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coopersurgical, INC. $106.83 2021
Bayer Healthcare Pharmaceuticals INC. $57.52 2020-2021
Abbvie INC. $32.87 2021
Avion Pharmaceuticals $32.24 2021
Therapeuticsmd, INC. $27.71 2021
Mylan Pharmaceuticals INC. $17.81 2021
Hologic Sales and Service, LLC $16.85 2024 Acessa Provu System, Myosure Tissue Removal Device, Novasure
Medtronic, INC. $13.65 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ariel E Holley

$305.48

in general payments reported 2019-2025

Years
2020-2024
Top company
Coopersurgical, INC.

https://glasscript.com/doctor/302644/ariel-e-holley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.